SNAPDUO Trademark

Trademark Overview


On Wednesday, December 4, 2024, a trademark application was filed for SNAPDUO with the United States Patent and Trademark Office. The USPTO has given the SNAPDUO trademark a serial number of 98884892. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 12, 2025. This trademark is owned by IDEXX Laboratories, Inc.. The SNAPDUO trademark is filed in the Medical Instrument Products category with the following description:

Device for determining the presence, absence, or quantity of antibiotic residue in a sample
snapduo

General Information


Serial Number98884892
Word MarkSNAPDUO
Filing DateWednesday, December 4, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, March 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDevice for determining the presence, absence, or quantity of antibiotic residue in a sample

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2024
Primary Code010
First Use Anywhere DateSaturday, February 29, 2020
First Use In Commerce DateSaturday, February 29, 2020

Trademark Owner History


Party NameIDEXX Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestbrook, ME 04092

Trademark Events


Event DateEvent Description
Wednesday, December 4, 2024NEW APPLICATION ENTERED
Wednesday, March 5, 2025ASSIGNED TO EXAMINER
Wednesday, December 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 12, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 12, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED